American Society of Human Genetics (ASHG)
Forge lasting collaborations, present emerging science, and explore new tools & technologies that will transform your science and accelerate your career growth only at ASHG’s Annual Meeting.
12 events found.
Events
-
-
-
-
QIAGEN IPA deep-dive training, Europe and Middle East
Virtual - EMEA - CETJoin us for a 90-minute training session to learn more about the advanced features of QIAGEN IPA
-
IPA deeper dive: miRNA investigation using QIAGEN Ingenuity Pathway Analysis (IPA)
Virtual - Americas - EST , United StatesIn this 90-minute training session, you will learn how to identify target mRNAs for your miRNAs of interest and associate them with pathways, diseases, biological functio ns, tissues and cell types.
-
-
Drug treatment, toxicology and target safety assessment using QIAGEN IPA and OmicSoft
Virtual - Americas - EST , United StatesIn this 90-minute training, you’ll learn how to do drug treatment, toxicology and target safety assessment-related discoveries using QIAGEN Ingenuity Pathway Analysis (IPA) and QIAGEN Omicsoft Lands. Using public data […]
-
Comprehensive Molecular Tumor Analysis with Alacris Theranostics
FeaturedVirtual - Americas - EST , United StatesJoin Dr. Marie-Laure Yaspo, Co-Founder and Chief Scientific Officer of Alacris Theranostics, as she discusses the development, application, and analysis of the Comprehensive Molecular Tumor Analysis (CMTA) test for cancer […]
-
New user training: Large dataset analysis and knowledge base queries using QIAGEN Ingenuity Pathway Analysis (IPA)
Virtual - Americas - EST , United StatesJoin us for a 90-minute training session for new users of QIAGEN IPA. Users will learn how to: • Upload their dataset (RNA-seq, scRNA-seq, proteomics, metabolomics and more) and perform […]
-
Isolate Typing, Strain Identification and Anti-Microbial Resistance Analyses Using QIAGEN CLC Genomics Workbench
Virtual - Americas - EST , United StatesQIAGEN CLC Genomics Workbench provides tools and workflows for a broad range of bioinformatics applications, including microbiome analysis, isolate characterization through SNP and K-mer trees using NGS data, and antimicrobial […]
-
Authenticated and reproducible cell line 'omics data
FeaturedVirtual - Americas - EST , United StatesAttend our joint webinar with ATCC to learn about and explore ATCC Cell Line Land.
-
Biomarker discovery and disease pathology investigation using QIAGEN OmicSoft and Ingenuity Pathway Analysis
Virtual - Americas - EST , United StatesIn this training, attendees will learn how to harness curated ‘omics datasets in OmicSoft DiseaseLand and curated research findings in IPA to discover new potential biomarkers. Using a neurological disorder […]
-
IPA deeper dive: Generating novel discoveries in IPA - even when you don’t have data
Virtual - Americas - EST , United StatesTake a deeper dive into the discovery capabilities of QIAGEN IPA. In this training, you will learn how to: • Leverage the IPA knowledge base to generate hypotheses regarding novel biological mechanisms, discover biomarkers and targets as well as design experiments. • Generate interactive networks using genes, chemicals and diseases of interest • Search and […]
-
Lowering NGS analysis cost at lightspeed
Virtual - Americas - EST , United StatesAdvances in next-generation sequencing (NGS) technologies over the years have significantly decreased the cost of whole genome (WGS) and whole exome (WES) applications, such that they are considered the standard of care within multiple healthcare organizations. Arguably, the most significant NGS challenges lie within data analysis and interpretation. Various parameters such as sensitivity, specificity, cost […]
-
How to simplify somatic NGS analysis & reduce literature review time by 90% with HSMD
FeaturedVirtual - Americas - EST , United StatesAcross clinical oncology applications, from molecular testing to cancer research, the ability to identify potentially actionable genomic and genetic alterations to exploit the molecular vulnerabilities of cancer is a burgeoning field. Due to the sporadic nature of somatic cancers and the expansion of next-generation sequencing, the number of variants detected through tumor testing is growing […]